Petros Pharmaceuticals, Inc.
PTPI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -12.2% | -2.8% | -23.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 76.3% | 72% | 61.8% | 79.5% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -211.5% | -72.3% | -229.1% | -22.3% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -280.1% | -140.2% | -334.4% | -115% |
| EPS Diluted | -3.34 | -6.35 | -9.68 | -8.25 |
| % Growth | 47.4% | 34.4% | -17.3% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |